Page last updated: 2024-08-17

physostigmine and Migraine Disorders

physostigmine has been researched along with Migraine Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eyer, F; Jetzinger, E; Pfab, R; Zilker, T1

Other Studies

2 other study(ies) available for physostigmine and Migraine Disorders

ArticleYear
Withdrawal from high-dose tranylcypromine.
    Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:3

    Topics: Adult; Antidotes; Delirium; Heroin Dependence; Humans; Infusions, Intravenous; Male; Migraine Disorders; Monoamine Oxidase Inhibitors; Physostigmine; Substance Withdrawal Syndrome; Thrombocytopenia; Tranylcypromine

2008
[Need for gastric acidification in the treatment of abdominal migraine. Results of a multicenter study on the association of Séglor retard and Vagosérine].
    Medecine & chirurgie digestives, 1980, Volume: 9, Issue:6

    Topics: Adult; Aged; Dihydroergotamine; Drug Combinations; Female; Glutamates; Humans; Male; Middle Aged; Migraine Disorders; Papain; Physostigmine

1980